Rojas MG, Córdova UC, Sánchez LPJ

Language: Spanish
References: 15
Page: 76-80
PDF size: 383.96 Kb.

ABSTRACT

Background: Cervical cancer is early diagnosed by Papanicolaou, so it is considered one of the most successful tests. Studies about sensitivity and specificity of the Papanicolaou study and colposcopy have been made with varying results. For a better diagnosis, it is recommended to do cytology, colposcopy and biopsy.
Objective: To determine sensitivity and specificity of the Papanicolaou study and colposcopy in the histopathological diagnosis of cervical intraepithelial neoplasia and to establish agreement of such methods about the histopathological diagnosis at Special Unit Diagnostic Support Center San Rafael, ISSSTE.
Material and methods: We performed a descriptive, retrospective and transversal study from January 2008 to July 2009. We collected 112 files from the colposcopy service with histopathological report.
Results: Average age of the patients was 44.26 ± 12.64 years; quadratic-cells tables were performed, finding a sensitivity of 88.1% for cytology compared to the reported 75%, and the sensitivity of colposcopy was 88.1% compared to the reported 83%, with a concordance of 78% for cytology and 84% for colposcopy.
Conclusions: Both methods are complementary and nothing can substitute the histologic study.

REFERENCES

1. Rico-Morlán FJL, Barra Martínez R, Martínez Macías R, Santiago Vázquez RY. Cáncer cervicouterino; la importancia para el médico general. GAMO Mex 2009;8(3):127-131.

2. Parraguirre Martínez S, De Larios Nassira M, Martínez Madrigal JJ. Correlación citológica e histológica de la neoplasia intraepitelial cervical temprana. Tres años de revisión en el Hospital General Dr. Manuel Gea González. Rev Hosp Gral Dr M Gea González 2001;4(1-2):39-45.

3. Sánchez Hernández JA, Huerta Pineda MI, Rivera Tapia JA, Rosales Pérez M. Infección por VPH y cáncer cervicouterino. Rev Mex Patol Clin 2005;52(4):222-233.

4. Stark A, Gregorie L, Pilarski R, Zarbo A, et al. Human papillomavirus, cervical cancer and women’s knowledge. Cancer Detect Prev 2008;32(1):15-22.

5. De San José S, Diaz M, Castellsagué X, Clifford G, et al. World prevalence and genotype distribution of cervical human papaillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7:453-459.

6. Zamudio Andrade A, Zepeda Zaragoza J, Rodríguez Blanco B, Tenorio Marañón R. Evaluación del Papanicolaou y la colposcopia en el diagnóstico de la infección por el virus del papiloma humano. Rev Fac Med UNAM 2001;44(1):5-7.

7. Wright TC. Natural history of HPV infections. J Fam Pract 2009;58(9, Suppl X):S3-S7.

8. Lizano M, De la Cruz Hernández E, Carrillo García A, García Carrancá A, et al. Distribution of HPV 16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 2006;102:230-235.

9. Safaeian M, Solomon D. Cervical cancer prevention – cervical screening: Science in evolution. Obstet Gynecol Clin North Am 2007;34(4):739.

10. Koss LG. The Papanicolaou test for cervical cancer detection. JAMA 1989;261(5):737-743.

11. Rebol M, van Balleguoijen M, Lynge E, Looman C, et al. Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ 2009;338:b1354.

12. Guzmán González P, Alonso de Ruiz P, Córdova Ramírez S, González Mena LE. Revisión rápida versus revisión tradicional en el citodiagnóstico cervicovaginal. Comparación mediante correlación citohistológica. Rev Med Hosp Gral Mex 2007;70(3):102-106.

13. Lazcano Ponce EC, Nájera Aguilar P, Alonso de Ruiz P, Buiatti E, Hernández Ávila M. Programa de detección oportuna de cáncer cervical en México. 1. Diagnóstico situacional. Rev Inst Nal Cancerol Méx 1996;42(3):123-140.

14. Rodríguez Lundes O, Pichardo García R, Escamilla Godínez G, Hernández Valencia M. Estudio de la patología citológica del cérvix. Perinatol Reprod Hum 2009;23:12-17.

15. Bibbo M, Wilbur D. Comprehensive cytopathology: Philadelphia: Sauders; 1990:48-64.